These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 395787)

  • 1. [Biochemical aspects of folate transport].
    Totskiĭ VN; Bondarchuk NG
    Usp Sovrem Biol; 1979; 88(3):353-66. PubMed ID: 395787
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereochemical characteristics of the folate-antifolate transport mechanism in L1210 Leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Feb; 34(2):371-7. PubMed ID: 4855750
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies on the transport of aminopterin, methotrexate, and methasquin by the L1210 leukemia cell.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1972 Oct; 32(10):2120-6. PubMed ID: 4404161
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
    Zhao R; Gao F; Babani S; Goldman ID
    Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model system for the study of heteroexchange diffusion: methotrexate-folate interactions in L1210 leukemia and Ehrlich ascites tumor cells.
    Goldman ID
    Biochim Biophys Acta; 1971 Jun; 233(3):624-34. PubMed ID: 5113921
    [No Abstract]   [Full Text] [Related]  

  • 6. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sulfhydryl inhibitors upon transport of folate compounds into L1210 cells.
    Rader JI; Niethammer D; Huennekens FM
    Biochem Pharmacol; 1974 Jul; 23(14):2057-9. PubMed ID: 4472601
    [No Abstract]   [Full Text] [Related]  

  • 9. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
    Zhao R; Babani S; Gao F; Liu L; Goldman ID
    Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a folate binding protein in L1210 cells grown in low folate medium.
    Jansen G; Kathmann I; Rademaker BC; Braakhuis BJ; Westerhof GR; Rijksen G; Schornagel JH
    Cancer Res; 1989 Apr; 49(8):1959-63. PubMed ID: 2702638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
    Westerhof GR; Jansen G; van Emmerik N; Kathmann I; Rijksen G; Jackman AL; Schornagel JH
    Cancer Res; 1991 Oct; 51(20):5507-13. PubMed ID: 1655252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on a novel class of genetic variants of the L1210 cell with increased folate analogue transport inward. Transport properties of a new variant, evidence for increased levels of a specific transport protein, and its partial characterization following affinity labeling.
    Yang CH; Sirotnak FM; Mines LS
    J Biol Chem; 1988 Jul; 263(20):9703-9. PubMed ID: 2838477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells.
    Henderson GB; Strauss BP
    Cancer Res; 1990 Mar; 50(6):1709-14. PubMed ID: 2306724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between carrier-mediated transport of folate compounds by L1210 leukemia cells: evidence for multiplicity of entry routes with different kinetic properties expressed in plasma membrane vesicles.
    Yang CH; Dembo M; Sirotnak FM
    J Membr Biol; 1983; 75(1):11-20. PubMed ID: 6887234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of folate antagonists on the metabolism of folic acid and its reduced derivatives in rat liver and kidney.
    Bühring U; Shin YS; Fölsch E
    Cancer Res; 1977 Jan; 37(1):299-304. PubMed ID: 830415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mathematical description and study of the folic acid cycle reactions].
    Vorontsov IN; Greshilov MM; Belousova AK; Gerasimova GK
    Biokhimiia; 1980 Jan; 45(1):83-97. PubMed ID: 6783126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
    Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacologic properties of a new folate analog, 10-deaza-aminopterin, in mice.
    Sirotnak FM; DeGraw JI; Chello PL; Moccio DM; Dorick DM
    Cancer Treat Rep; 1982 Feb; 66(2):351-8. PubMed ID: 7055818
    [No Abstract]   [Full Text] [Related]  

  • 19. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
    Kühnel JM; Chiao JH; Sirotnak FM
    J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive dihydrofolate reductase binding assay of triazinate (NSC-139105), methasquin (NSC-122870), and aminopterin (NSC739).
    Myers CE; Eliot HM; Chabner BA
    Cancer Treat Rep; 1976 May; 60(5):615-6. PubMed ID: 1033031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.